Olgu Sunumu
PDF EndNote BibTex RIS Kaynak Göster

Prognosis and treatment of COVID-19 infection while receiving treatment for comorbid active tuberculosis: report of two cases

Yıl 2022, Cilt 5, Sayı 2, 51 - 55, 30.09.2022
https://doi.org/10.33204/mucosa.1115584

Öz

Tuberculosis is still a serious public health issue in underdeveloped countries. There is presently little clinical experience with the co-existence of tuberculosis and COVID-19 infection, presented as the severe acute respiratory syndrome coronavirus 2 infection, which was first observed in China in December 2019. This case report details the diagnostic and treatment stages of two patients who had active tuberculosis and COVID-19 infection, as well as the outcomes of their therapies, both of which were effective.

Kaynakça

  • World Health Organization. Global tuberculosis report 2020.
  • https://www.who.int/emergencies/diseases/novelcoronavirus-2019/situation-reports/ Accessed 28.09.2022.
  • https://covid19.saglik.gov.tr/ Accessed 28.09.2022.
  • Leung CC, Lam TH, Cheng KK. Let us not forget the mask in our attempts to stall the spread of COVID-19. Int J Tuberc Lung Dis 2020;24:364-6.
  • Noia Maciel EL, Gonçalves Junior E, Pretti Dalcolmo MM.Tuberculosis and coronavirus: what do we know? Epidemiol Serv Saude 2020;29:e2020128.
  • Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020;75:1730-41.
  • Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA 2020;323:1239-42.
  • Chen Y, Wang Y, Fleming J, et al. Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. MedrxivmedRxiv preprint. Mar. 2020. Available at: https://www.medrxiv.org/ content/10.1101/2020.03.10.20033795v1.full.pdf. Accessed 28.09.2022.
  • Tadolini M, Codecasa LR, Garcia-Garcia JM, et al. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J 2020;56:2001398.

Aktif tüberküloz tedavisi sırasında gelişen COVID-19 enfeksiyonunun tedavi ve prognozu: İki olgu sunumu

Yıl 2022, Cilt 5, Sayı 2, 51 - 55, 30.09.2022
https://doi.org/10.33204/mucosa.1115584

Öz

Tüberküloz, az gelişmiş ülkelerde hala ciddi bir halk sağlığı sorunudur. Tüberküloz ve COVID-19 enfeksiyonunun birlikteliği ile ilgili çok az sayıda klinik deneyim mevcuttur. COVID-19 enfeksiyonu ilk kez şiddetli akut solunum sendromu tablosu olarak Çin’de Aralık 2019’da görülmüştür. Bu raporda aktif tüberkülozu ve COVID-19 enfeksiyonu olan iki hastanın tanı ve başarılı olan tedavi aşamaları detaylı olarak sunulmuştur.

Kaynakça

  • World Health Organization. Global tuberculosis report 2020.
  • https://www.who.int/emergencies/diseases/novelcoronavirus-2019/situation-reports/ Accessed 28.09.2022.
  • https://covid19.saglik.gov.tr/ Accessed 28.09.2022.
  • Leung CC, Lam TH, Cheng KK. Let us not forget the mask in our attempts to stall the spread of COVID-19. Int J Tuberc Lung Dis 2020;24:364-6.
  • Noia Maciel EL, Gonçalves Junior E, Pretti Dalcolmo MM.Tuberculosis and coronavirus: what do we know? Epidemiol Serv Saude 2020;29:e2020128.
  • Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020;75:1730-41.
  • Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA 2020;323:1239-42.
  • Chen Y, Wang Y, Fleming J, et al. Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. MedrxivmedRxiv preprint. Mar. 2020. Available at: https://www.medrxiv.org/ content/10.1101/2020.03.10.20033795v1.full.pdf. Accessed 28.09.2022.
  • Tadolini M, Codecasa LR, Garcia-Garcia JM, et al. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J 2020;56:2001398.

Ayrıntılar

Birincil Dil İngilizce
Konular Tıp
Bölüm Case Reports
Yazarlar

Yelda VAROL>
UNIVERSITY OF HEALTH SCIENCES, İZMİR DR. SUAT SEREN HEALTH RESEARCH CENTER FOR PULMONOLOGY AND THORACIC SURGERY
0000-0003-4604-7173
Türkiye


Hilal ÖZDEMİR DEMİRCİ> (Sorumlu Yazar)
UNIVERSITY OF HEALTH SCIENCES, İZMİR DR. SUAT SEREN HEALTH RESEARCH CENTER FOR PULMONOLOGY AND THORACIC SURGERY
0000-0003-4643-7438
Türkiye


Onur KARAMAN>
UNIVERSITY OF HEALTH SCIENCES, İZMİR DR. SUAT SEREN HEALTH RESEARCH CENTER FOR PULMONOLOGY AND THORACIC SURGERY
0000-0002-4384-3732
Türkiye


Tülay AKARCA>
UNIVERSITY OF HEALTH SCIENCES, İZMİR DR. SUAT SEREN HEALTH RESEARCH CENTER FOR PULMONOLOGY AND THORACIC SURGERY
0000-0001-8781-4485
Türkiye


Diğdem ÖZBAKIR>
UNIVERSITY OF HEALTH SCIENCES, İZMİR DR. SUAT SEREN HEALTH RESEARCH CENTER FOR PULMONOLOGY AND THORACIC SURGERY
0000-0002-3179-5235
Türkiye

Yayımlanma Tarihi 30 Eylül 2022
Yayınlandığı Sayı Yıl 2022, Cilt 5, Sayı 2

Kaynak Göster

Vancouver Varol Y. , Özdemir Demirci H. , Karaman O. , Akarca T. , Özbakır D. Prognosis and treatment of COVID-19 infection while receiving treatment for comorbid active tuberculosis: report of two cases. Mucosa. 2022; 5(2): 51-55.